Barrett's esophagus: can biomarkers predict progression to malignancy? Expert Rev Gastroenterol Hepatol 2008;2:653-663.Tischoff, I, Tannapfel, A (2008) Barrett’s esophagus: can biomarkers predict progression to malignancy?. Expert Rev Gastroenterol Hepatol 2: pp. 653-663...
BACKGROUND: Surgical treatment in patients with gastroesophageal reflux disease (GERD) without Barrett's esophagus (BE) is an excellent alternative therapy to medical treatment, preventing the development of complications and the appearance of BE. PURPOSE: To determine the newly developed BE in a grou...
The histological distinction between intestinal metaplasia involving the distal esophagus (Barrett's esophagus [BE]) and intestinal metaplasia of the stomach has important clinical implications and can be difficult even with the use of histochemical mucin stains. Cytokeratin (CK) 7 and 20 are cytoplasmi...
doi:10.1038/ncpgasthep0614NoneNature Clinical Practice Gastroenterology & 38 Hepatology
Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma. Cancer Lett. 2016, 370, 117–124. [Google Scholar] [CrossRef] [PubMed] Lin, S.-J.; Chen, J.-Y.; Kuo, M.-L.; Hsiao, H.-S....
llance Biopsies?]]>doi:10.1016/S0016-5085(15)30317-6Leggett, Cadman L.Chan, Daniel K.Gorospe, Emmanuel C.Nehra, AkhilAnderson, MarlysLutzke, Lori S.Wang, Kenneth K.Elsevier Inc.Gastroenterology
Mucosectomy for high-grade dysplasia in Barrett's esophagus. Reports on the natural history of high-grade dysplasia (HGD) are sometimes contradictory, but suggest that 10-30% of patients with HGD in Barrett's esophag... Massimo,Picasso,Sabrina,... - 《Minimally Invasive Therapy & Allied Techn...
Rugge M,Meggio A,Cataudella G,Parente P,Salvagnini G,de Pretis G,Zaninotto G.Barrett’’s esophagus: still much to learn, but "Yes, we can!".The American journal of Gastroenterology. 2008Barrett’’s esophagus: still much to learn, but "Yes, we can!". Rugge M,Meggio A,Cat...
Purpose of Review Despite gastrointestinal societal recommendations for endoscopic screening and surveillance of Barrett's esophagus, the rates of esophageal adenocarcinoma continue to rise...doi:10.1007/s11894-019-0685-6Konda, Vani J. A.Souza, Rhonda F.Springer...
Both types of regression were significantly more common in short (< 3 cm) than long (> 3 cm) segment Barrett's esophagus; 19 of 33 (58%) and 9 of 44 (20%) patients, respectively (p = 0.0016). Eight patients progressed, five from IM alone to low-grade dysplasia and three from ...